It has been over 11 years since Chinese President Xi Jinping announced the Belt and Road Initiative. Since then, hundreds of billions of dollars have flowed from China to infrastructure projects ...

Here’s how it works. The best running belts make it easy to carry your essentials without the hassle. No more bulging pockets in your running shorts or leggings, or juggling your phone ...

NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on ...

Helius Medical (HSDT) Technologies announced positive results from the PoNS Therapeutic Experience Program, or PoNSTEP, study for people with multiple sclerosis. PoNSTEP Results: There were ...

Helius Medical (HSDT) Technologies announced it has completed and far exceeded the initial target enrollment for its stroke registrational program. With 128 participants randomized to-date the ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 million, has surpassed its initial enrollment target for its stroke ...

As you can see from the chart above the percentage of shares that are sold short for Helius Medical Tech has grown since its last report. This does not mean that the stock is going to fall in the ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $2.8 million, has surpassed its initial enrollment target for its stroke ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...

(RTTNews) - Helius Medical Technologies (HSDT), a neurotech company focused on innovative treatments for neurological deficits, on Tuesday announced strong progress in its stroke registrational ...

Helius Medical Technologies, Inc. announced agreements with warrant holders to exercise nearly 4.97 million shares of common stock at a reduced price of $0.751 per share, generating approximately ...